J 2020

TGF-beta regulates Sca-1 expression and plasticity of pre-neoplastic mammary epithelial stem cells

REMŠÍK, Ján, Markéta PÍCKOVÁ, Ondřej VACEK, Radek FEDR, Lucia BINO et. al.

Basic information

Original name

TGF-beta regulates Sca-1 expression and plasticity of pre-neoplastic mammary epithelial stem cells

Authors

REMŠÍK, Ján (703 Slovakia, belonging to the institution), Markéta PÍCKOVÁ (203 Czech Republic, belonging to the institution), Ondřej VACEK (203 Czech Republic, belonging to the institution), Radek FEDR, Lucia BINO, Aleš HAMPL (203 Czech Republic, belonging to the institution) and Karel SOUČEK (203 Czech Republic, guarantor, belonging to the institution)

Edition

Scientific reports, London, Nature Publishing Group, 2020, 2045-2322

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30204 Oncology

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 4.379

RIV identification code

RIV/00216224:14310/20:00117612

Organization unit

Faculty of Science

UT WoS

000548564900110

Keywords in English

Breast cancer; Cancer stem cells

Tags

International impact, Reviewed
Změněno: 1/4/2021 10:50, Mgr. Marie Šípková, DiS.

Abstract

V originále

The epithelial-mesenchymal plasticity, in tight association with stemness, contributes to the mammary gland homeostasis, evolution of early neoplastic lesions and cancer dissemination. Focused on cell surfaceome, we used mouse models of pre-neoplastic mammary epithelial and cancer stem cells to reveal the connection between cell surface markers and distinct cell phenotypes. We mechanistically dissected the TGF-beta family-driven regulation of Sca-1, one of the most commonly used adult stem cell markers. We further provided evidence that TGF-beta disrupts the lineage commitment and promotes the accumulation of tumor-initiating cells in pre-neoplastic cells.

Links

EF16_025/0007381, research and development project
Name: Preklinická progrese nových organických sloučenin s cílenou biologickou aktivitou